anmelden
OMX Nordic 40
2.715,53
PKT
-2,53
PKT
-0,09
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.06.23 | AstraZeneca Overweight | Barclays Capital | |
| 05.06.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.06.23 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 02.06.23 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 02.06.23 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
| 01.06.23 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 26.05.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 26.05.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 26.05.23 | Novo Nordisk Sell | UBS AG | |
| 25.05.23 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 24.05.23 | Nokia Outperform | Credit Suisse Group | |
| 23.05.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 23.05.23 | Novo Nordisk Overweight | Barclays Capital | |
| 23.05.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 23.05.23 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 22.05.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 22.05.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 22.05.23 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 18.05.23 | AstraZeneca Neutral | UBS AG | |
| 17.05.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.05.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 16.05.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.05.23 | Nokia Overweight | JP Morgan Chase & Co. | |
| 11.05.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 11.05.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 11.05.23 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 09.05.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 09.05.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 09.05.23 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.05.23 | A.P. Moeller - Maersk A-S (B) Neutral | UBS AG | |
| 05.05.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.05.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.05.23 | A.P. Moeller - Maersk A-S (B) Overweight | JP Morgan Chase & Co. | |
| 05.05.23 | Novo Nordisk Outperform | Credit Suisse Group | |
| 04.05.23 | Novo Nordisk Sell | UBS AG | |
| 04.05.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 03.05.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 03.05.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 03.05.23 | Volvo (B) Hold | Jefferies & Company Inc. | |
| 02.05.23 | Volvo (B) Buy | Goldman Sachs Group Inc. |
